By Pushkala Aripaka and Bhanvi Satija Jan 20 (Reuters) - Britain's GSK has agreed to buy RAPT Therapeutics for $2.2 billion, ...

The growing scourge of food allergies drove U.K. heavyweight GSK to announce a $2.2 billion deal on Tuesday.

TIANJIN, China, Jan. 26, 2026 /PRNewswire/ -- In a landmark move for the cell therapy industry, a Device Master File (DMF) ...

Thailand’s Public Health Ministry is ramping up efforts to combat the rising obesity rates and the broader issue of NCDs ...

The agency issued a request for more information that will shape new regulation on ingredient transparency.

Americans who smoke may soon be hearing a lot more about Zyn. That's the flavored nicotine pouch that's generated billions in ...

Looser regulations around consumer-grade wearable devices could be a "path to ROI" for health systems—or a "double-edged ...

45 illnesses and 12 hospitalizations have been reported so far.

Live Action alleges "reckless distribution" of the abortion drug mifepristone, urging the Trump administration to suspend its ...

The U.S. Food and Drug Administration (FDA) has upgraded a voluntary recall of grated Pecorino Romano cheese products to a ...

Flavored nicotine pouches called Zyn could soon be legally advertised as a lower-risk option for adults who smoke, as federal ...

The Food and Drug Administration announced that a recall of cookie products has been upgraded to its most serious risk ...